
Bravatek
High technology security solutions portfolio provider.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | $500k | Growth Equity VC | |
Total Funding | 000k |
Bravatek Solutions, Inc. operates as a high-technology security solutions portfolio provider, assisting corporate entities, governments, and individuals in protecting their organizations from both physical and cyber-attacks. The company was incorporated as Ecrypt Technologies, Inc. on April 19, 2007, in Colorado and later changed its name to Bravatek Solutions on November 10, 2015. It was founded by Brad Lever, Gabriel Rosu, and Kasia Zukowska. Publicly traded on the OTC PINK market under the symbol BVTK, the company filed its Form 10 Registration Statement with the SEC on November 10, 2008.
The company's business model revolves around the marketing and distribution of security, defense, and information security software, tools, and systems. Revenue is generated through sales commissions, licensing of its proprietary software, and joint ventures. Bravatek's strategy involves forming strategic alliances and partnerships to expand its portfolio and market reach. The company targets high-growth markets, including healthcare, government and military sectors, law enforcement, legal services, financial services, and critical infrastructure owners.
Bravatek's offerings are categorized into software, tools, and systems. Key products include EcryptOne, a proprietary email protection software with a white-list mentality for controlling information flow; Tuitio, an endpoint security solution that blocks malicious code without relying on signature recognition; and Distributed Acoustic Sensing (DAS) Fiber Technology for real-time monitoring of assets in industries like oil and gas, and transport. The company has also been involved in commercializing chemical, explosive, and drug sensors developed at Pacific Northwest National Laboratory and offers autonomous drone-based monitoring systems.
Leading the company is Chairman and CEO, Dr. Thomas A. Cellucci, an accomplished entrepreneur with extensive experience in both corporate and government sectors. Before joining Bravatek, Dr. Cellucci served as the first Chief Commercialization Officer at the U.S. Department of Homeland Security under two presidential administrations. His background includes a Ph.D. in Physical Chemistry from the University of Pennsylvania and an MBA from Rutgers University, and he has a track record of growing high-technology firms. However, in April 2020, the SEC temporarily suspended trading of Bravatek's securities due to questions regarding the accuracy of information the company disseminated in press releases and social media posts.
Keywords: security solutions, cybersecurity, physical security, government security, critical infrastructure protection, email security, endpoint protection, Distributed Acoustic Sensing, DAS technology, public company, OTC PINK, BVTK, security software, defense technology, information security, telecom services, first responders tools, military technology, corporate security, compliance solutions